Many thanks to reporter Camilo Fonseca for his reporting on the growing incidence across the country of silicosis, which has reached the Massachusetts stone countertop industry in the case of a worker ...
Visakhapatnam: A team of researchers from Andhra Medical College, Visakhapatnam and several other institutions not only from India, but also from the United States and the United Kingdom, assessed an ...
Christy Houvouras exercises daily, eats right and has smoked fewer than 20 cigarettes in her lifetime. That’s why she was shocked when she was diagnosed with lung cancer at just 36 years old in July. ...
When it comes to determining how or why some of her patients initially present with more significant lung destruction, MeiLan K. Han, MD, likened the role of the pulmonologist to that of a forensic ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage diagnostics including CyPath® Lung, the Company’s noninvasive test for lung cancer, today announced ...
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury Thermo Fisher Scientific, the world leader in serving science, has introduced a new laboratory ...
LungScope: An Intelligent Embedded System With a Lightweight Model for Real-Time Lung Sound Analysis
Abstract: Lung auscultation is crucial for early respiratory disease diagnosis. However, limited resources hinder accurate and timely assessment in many regions. In this article, we present LungScope, ...
Immerse yourself in tranquility with our video, "Take A Deep Breath 💙 Relaxing Zen Music with Peaceful Water Sounds." Designed to help you unwind, this experience combines calming Zen music with the ...
Introduction: In recent years, advancements in machine learning and electronic stethoscope technology have enabled high-precision recording and analysis of lung sounds, significantly enhancing ...
Pliant Therapeutics has terminated its idiopathic pulmonary fibrosis (IPF) program after digging into the increased rate of adverse events from a 2b/3 trial of its lead candidate bexotegrast. Back in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results